Literature DB >> 30053275

SHOULD PERSONNEL OF NUCLEAR MEDICINE DEPARTMENTS USE PERSONAL DOSIMETERS FOR EYE LENS DOSE MONITORING?

Hanna Piwowarska-Bilska1, Aleksandra Supinska2, Jacek Iwanowski1, Bozena Birkenfeld1.   

Abstract

Staff at nuclear medicine departments receive doses of ionising radiation higher than the staff of radiotherapy and radiology departments, with the exception of interventional radiologists. Due to the updated lower occupational exposure limit for the lens of the eye, we measured eye exposure in workers of the Nuclear Medicine Department, Pomeranian Medical University in Szczecin, Poland. EYE-D™ dosimeters were used for 3 months by 10 employees working with sources of ionising radiation. Personal dosimeters also measured the exposure of the whole body and hands. The 3-month dose equivalents for the lens of the eye in the employees was 0.20-0.72 mSv. Staff at NMD PMU do not require regular routine eye lens dose monitoring. Eye lens doses were well within the new annual limit of 20 mSv. Doses to the whole body may be used as an indicator of the eye lens doses in the monitored department.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Mesh:

Substances:

Year:  2019        PMID: 30053275     DOI: 10.1093/rpd/ncy118

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  ESTIMATION OF HP(3) AMONG STAFF MEMBERS IN TWO NUCLEAR MEDICINE UNITS IN FINLAND.

Authors:  C Lindholm; A Pekkarinen; O Sipilä; A-L Manninen; M Lehtinen; T Siiskonen
Journal:  Radiat Prot Dosimetry       Date:  2020-08-28       Impact factor: 0.972

2.  Radiation Dose to the Eye Lens Through Radiological Imaging Procedures at the Surgical Workplace During Trauma Surgery.

Authors:  Christian Apelmann; Birgitt Kowald; Nils Weinrich; Jens Dischinger; Albert Nienhaus; Klaus Seide; Heiko Martens; Christian Jürgens
Journal:  Int J Environ Res Public Health       Date:  2019-10-11       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.